Comments
Dr Reddy’s Laboratories announced that it has launched Montelukast Sodium Oral Granules, a bioequivalent generic version of Singulair (montelukast sodium) oral granules, in the US market. The drug is used for treating asthma and seasonal allergies. The move follows the approval by the United States Food & Drug Administration (USFDA) of Dr Reddy’s Abbreviated New Drug Application for Montelukast Sodium Oral Granules, a company press release said. The Singulair oral granules brand had US sales of approximately $61 million for the most recent twelve months ending July, according to IMS Health. Dr Reddy’s Montelukast Sodium oral granules in 4 mg are available in unit dosage package of 30.
Comments
COMMENT NOW
Comments
Comments have to be in English, and in full sentences. They cannot be abusive or personal. Please abide by our community guidelines for posting your comments.
We have migrated to a new commenting platform. If you are already a registered user of TheHindu Businessline and logged in, you may continue to engage with our articles. If you do not have an account please register and login to post comments. Users can access their older comments by logging into their accounts on Vuukle.